The Oxford-AstraZeneca vaccine is a «viral vector» vaccine, when the vaccine is injected into a patient, it manifests as a carrier another virus adapted to fight Coronavirus. It prompts the immune system to start making antibodies for to attack any covid-19 infection.
British pharma giant AstraZeneca announced that its Oxford-AstraZeneca vaccine (AZD1222), is 70 percent effective in protecting against the virus. This vaccine can be kept at refrigerator temperatures of 2 to 8 degrees Celsius.
Inexpensive, practical and easy to store, it has many advantages :
The AstraZeneca / Oxford vaccine has the majore advantage of being inexpensive at a maximum cost of $3 a dose (about 2.50 euros ), and easy to store.
Who will get the Oxford-AstraZeneca vaccine and when?
The UK has ordered 100 million doses of the Oxford-AstraZeneca vaccine, with the hope to about 100,000 doses will be received in the january 2021. AstraZeneca company signed deals to prepare at least 300 million doses for the U.S and more than 400 million for European Union members.
India approves Oxford-AstraZeneca Covid-19 vaccine
The Indian government has approved the Oxford/AstraZeneca Covid-19 vaccine for emergency use India, which has the highest number of infections after the U.S, it is the first vaccine to get approval in India.
More than 50 million doses of the Oxford-AstraZeneca vaccine have already been stockpiled by the Serum Institute of India (SII), the vaccination programme aims to reach 200 million people by early July 2021.